CO · Healthcare

H Lundbeck A/S (HLUN-B)

Drug Manufacturers - Specialty & Generic

H Lundbeck A/S (HLUN-B) is listed on CO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HLUN-B

P/E ratio

18.00

H Lundbeck A/S (HLUN-B) — FAQ

What is HLUN-B's P/E ratio?

The price-to-earnings (P/E) ratio for H Lundbeck A/S (HLUN-B) is 18.00 (data as of 2026-03-22).

Does H Lundbeck A/S pay a dividend?

Dividend yield is not available in the current snapshot for H Lundbeck A/S (HLUN-B). Check the MyAverix Finance app for the latest dividend data.

What sector is H Lundbeck A/S in?

H Lundbeck A/S (HLUN-B) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is HLUN-B listed on?

HLUN-B is listed on CO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)